224 related articles for article (PubMed ID: 16929590)
1. Does Silybum marianum play a role in the treatment of chronic hepatitis C?
Torres M; Rodríguez-Serrano F; Rosario DJ; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):69-74. PubMed ID: 16929590
[TBL] [Abstract][Full Text] [Related]
2. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.
Gordon A; Hobbs DA; Bowden DS; Bailey MJ; Mitchell J; Francis AJ; Roberts SK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):275-80. PubMed ID: 16460486
[TBL] [Abstract][Full Text] [Related]
3. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
[TBL] [Abstract][Full Text] [Related]
4. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.
Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Vinson S; Mousa M; Gitnick G
Am J Kidney Dis; 2000 Jan; 35(1):122-9. PubMed ID: 10620553
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Lee MH; Kim YM; Kim SG
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
[TBL] [Abstract][Full Text] [Related]
6. Artichoke leave extract for chronic hepatitis C - a pilot study.
Huber R; Müller M; Naumann J; Schenk T; Lüdtke R
Phytomedicine; 2009 Sep; 16(9):801-4. PubMed ID: 19427774
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.
van Rossum TG; Vulto AG; Hop WC; Schalm SW
Am J Gastroenterol; 2001 Aug; 96(8):2432-7. PubMed ID: 11513186
[TBL] [Abstract][Full Text] [Related]
8. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the relationship between serum nitric oxide levels, HBV-DNA and ALT levels in chronic hepatitis B patients].
Sener AG; Kirdar S; Serter M; Afşar I; Demir EM; Ceylan C; Aydin N
Mikrobiyol Bul; 2009 Jan; 43(1):83-9. PubMed ID: 19334384
[TBL] [Abstract][Full Text] [Related]
12. Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection.
Tseng GY; Lin HJ; Fang CT; Cheng YT; Huang CH; Tseng GC; Wang PC; Hung TL; Deng YC; Tsai CC; Yang KY
Ren Fail; 2008; 30(10):1000-5. PubMed ID: 19016152
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis caused by tick-borne meningoencephalitis virus (TBEV)--a rare clinical manifestation outside the central nervous system involvement].
Misić-Majerus L; Bujić N; Madarić V; Avsić-Zupanc T
Acta Med Croatica; 2005; 59(4):347-52. PubMed ID: 16334744
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
Orlent H; Hansen BE; Willems M; Brouwer JT; Huber R; Kullak-Ublick GA; Gerken G; Zeuzem S; Nevens F; Tielemans WC; Zondervan PE; Lagging M; Westin J; Schalm SW
J Hepatol; 2006 Oct; 45(4):539-46. PubMed ID: 16905220
[TBL] [Abstract][Full Text] [Related]
15. Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).
Tamayo C; Diamond S
Integr Cancer Ther; 2007 Jun; 6(2):146-57. PubMed ID: 17548793
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis.
Aghazadeh S; Amini R; Yazdanparast R; Ghaffari SH
Exp Toxicol Pathol; 2011 Sep; 63(6):569-74. PubMed ID: 20471811
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy.
Lawitz EJ; Hepburn MJ; Casey TJ
Am J Gastroenterol; 2004 Dec; 99(12):2359-64. PubMed ID: 15571583
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects.
Adebajo AC; Iwalewa EO; Obuotor EM; Ibikunle GF; Omisore NO; Adewunmi CO; Obaparusi OO; Klaes M; Adetogun GE; Schmidt TJ; Verspohl EJ
J Ethnopharmacol; 2009 Feb; 122(1):10-9. PubMed ID: 19095054
[TBL] [Abstract][Full Text] [Related]
20. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
